Global Bronchodilators Market 2017-2021

Publisher Name :
Date: 26-Jul-2017
No. of pages: 83
Price : Single User: US $ 3500  US $ 2500 Corporate User: US $ 5000  US $ 4000
Inquire Before Buying
Avail $1000 Discount on this report till 31 August 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Bronchodilators are a type of medication, which make breathing easy by relaxing the muscles in the lungs and widening the airways (bronchi). They are used to treat the breathing problems, majorly asthma and COPD.

Short-acting bronchodilators are the first-line therapy, which is widely used in bronchodilators. These agents have a short-term (2-4 hours) duration of action and therefore require multiple dosages.

Whereas, long-acting bronchodilators, which are introduced recently, have an extended period of action. They reduce the process of multiple dosages. Therefore, they are more effective than the short-term bronchodilators.

The analysts forecast global bronchodilators market to grow at a CAGR of 4.78% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global bronchodilators market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


The report, Global Bronchodilators Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • AstraZeneca

  • Boehringer Ingelheim

  • F. Hoffmann-La Roche

  • GlaxoSmithKline


Other prominent vendors


  • ALK-Abello

  • Amgen

  • Array BioPharma

  • ASMACURE

  • Astellas Pharma

  • Atopix Therapeutics

  • CHIESI Farmaceutici

  • Dynavax Technologies

  • Kissei Pharmaceutical

  • Kyowa Hakko Kirin

  • MediciNova

  • Mitsubishi Tanabe Pharma

  • Mundipharma International

  • Nycomed Pharma

  • Oxagen

  • Pearl Therapeutics

  • Pharmaxis

  • Pulmagen Therapeutics

  • Regeneron Pharmaceuticals

  • Revalesio

  • Sanofi

  • SolAeroMed

  • Stallergenes Greer

  • sterna biologicals

  • Synairgen

  • Theron Pharmaceuticals

  • UCB Pharma

  • Verona Pharma


Market driver


  • Market potential toward mAb

  • For a full, detailed list, view our report


Market challenge


  • Increased preference for CAM

  • For a full, detailed list, view our report


Market trend


  • Innovative technologies for drug delivery

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2021 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

  • What are the market opportunities and threats faced by the key vendors?

  • What are the strengths and weaknesses of the key vendors?

Avail $1000 Discount on this report till 31 August 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Global Bronchodilators Market 2017-2021

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
Market outline

PART 05: Pipeline analysis

PART 06: Market landscape
Market overview
Five forces analysis

PART 07: Market segmentation by drug class
Anticholinergic bronchodilators
Adrenergic bronchodilators
Bronchodilator combinations
Methylxanthines

PART 08: Geographical segmentation
Bronchodilators market in Americas
Bronchodilators market in EMEA
Bronchodilators market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
Market drivers
Market challenges

PART 11: Market trends
Innovative technologies for drug delivery
Growing usage of home healthcare devices
Strong product pipeline

PART 12: Vendor landscape
Competitive scenario

PART 13: Key vendor analysis
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GlaxoSmithKline
Other prominent vendors

PART 14: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Types of bronchodilators
Exhibit 02: Pipeline landscape
Exhibit 03: Pipeline analysis
Exhibit 04: Usage of bronchodilators
Exhibit 05: Global bronchodilators market 2016-2021 ($ millions)
Exhibit 06: Opportunity analysis in global bronchodilators market
Exhibit 07: Five forces analysis
Exhibit 08: Global anticholinergic bronchodilators market 2016-2021 ($ millions)
Exhibit 09: Global adrenergic bronchodilators market 2016-2021 ($ millions)
Exhibit 10: Global bronchodilator combinations market 2016-2021 ($ millions)
Exhibit 11: Global methylxanthines bronchodilators market 2016-2021 ($ millions)
Exhibit 12: Global bronchodilators market based on geography 2016 and 2021 (%)
Exhibit 13: Bronchodilators market revenue by geography 2016-2021 ($ millions)
Exhibit 14: Market scenario in Americas
Exhibit 15: Bronchodilators market in Americas 2016-2021 ($ millions)
Exhibit 16: Market scenario in EMEA
Exhibit 17: Bronchodilators market in EMEA 2016-2021 ($ millions)
Exhibit 18: Market scenario in APAC
Exhibit 19: Bronchodilators market in APAC 2016-2021 ($ millions)
Exhibit 20: Recent approvals in mAb for bronchodilators market
Exhibit 21: Drugs expected to get approval in forecast period
Exhibit 22: Recent approvals in bronchodilators market
Exhibit 23: Drug approvals in COPD drugs market in past three years
Exhibit 24: COPD drug molecules in the stage of registration
Exhibit 25: Competitive structure analysis of global bronchodilators market 2016
Exhibit 26: Strategic success factors of companies in global bronchodilators market
Exhibit 27: AstraZeneca: Strength assessment
Exhibit 28: AstraZeneca: Strategy assessment
Exhibit 29: AstraZeneca: Opportunity assessment
Exhibit 30: Boehringer Ingelheim: Strength assessment
Exhibit 31: Boehringer Ingelheim: Strategy assessment
Exhibit 32: Boehringer Ingelheim: Opportunity assessment
Exhibit 33: F. Hoffmann-La Roche: Strength assessment
Exhibit 34: F. Hoffmann-La Roche: Strategy assessment
Exhibit 35: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 36: GlaxoSmithKline: Strength assessment
Exhibit 37: GlaxoSmithKline: Strategy assessment
Exhibit 38: GlaxoSmithKline: Opportunity assessment

  • Global Preventive Asthma Drugs Market Research Report 2017
    Published: 18-Aug-2017        Price: US 2900 Onwards        Pages: 125
    In this report, the global Preventive Asthma Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Preventive Asthma Drugs in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - Ch......
  • United States Bronchodilators Market Report 2017
    Published: 17-Aug-2017        Price: US 3800 Onwards        Pages: 114
    In this report, the United States Bronchodilators market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of ......
  • Global Bronchodilators Sales Market Report 2017
    Published: 11-Aug-2017        Price: US 4000 Onwards        Pages: 119
    In this report, the global Bronchodilators market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units) , revenue (Million USD) , market share and growth rate of Bronchodilators for these regions, from 2012 to 2022 (forecast) , covering - United States - China - Europe - Japan......
  • Global Bronchodilators Market Research Report 2017
    Published: 07-Aug-2017        Price: US 2900 Onwards        Pages: 113
    In this report, the global Bronchodilators market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Bronchodilators in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Jap......
  • Global Montelukast Sodium Sales Market Report 2017
    Published: 31-Jul-2017        Price: US 4000 Onwards        Pages: 111
    In this report, the global Montelukast Sodium market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Montelukast Sodium for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japa......
  • Global Asthma Therapeutics Market Size, Status and Forecast 2022
    Published: 28-Jul-2017        Price: US 3300 Onwards        Pages: 100
    This report studies the global Asthma Therapeutics market, analyzes and researches the Asthma Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - GSK - Merck - AstraZeneca - Boehringer Ingelheim - F. Hoffmann-La Roche - Teva Pharmaceutical - Theravance - Regeneron - Sanofi - Novartis - AB Science ......
  • Global Montelukast Sodium Market Research Report 2017
    Published: 26-Jul-2017        Price: US 2900 Onwards        Pages: 111
    In this report, the global Montelukast Sodium market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD) , market share and growth rate of Montelukast Sodium in these regions, from 2012 to 2022 (forecast) , covering - North America - Europe - China......
  • Asthma - Epidemiology Insights to 2025
    Published: 05-Jul-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight " Asthma - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Asthma in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Asthma prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Asthma. The report is built us......
  • Global Budesonide Aerosol Market Professional Survey Report 2017
    Published: 30-Jun-2017        Price: US 3500 Onwards        Pages: 111
    This report studies Budesonide Aerosol in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - AstraZeneca - Pfizer - Teva - Cipla - Novartis - My......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs